Recombinant DNA Technology Market - By Types (Expression System and Cloning Vector), By Product (Medical and Non-Medical), By Application (Diseases, Plants, and Others), and By End User (Research Institutes, Biotechnology Companies, and Pharmaceuticals) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

Recombinant DNA technology (rDNA) helps to identify the gene function and its regulation in normal and pathogenic condition. Recombinant DNA is created artificially from two or more DNA molecules, which are incorporated into a single molecule. Recombinant DNA technology examines the functioning of the living system by manipulating their genome for production of useful metabolites. Recombinant DNA technology has introduced new classes of organism namely genetically modified organism (GMO) or living modified organism (LMO).  It can develop genetically modified crops (BT cotton), cloned animals, bio pesticides, biofuel, bioremediation, and gene therapy successfully. Impact of rDNA on human and environment in the context of safety is assessed by researchers.

Advance rDNA technology have resulted in production of various therapeutic proteins, such as insulin, hormones, edible vaccines, interleukins, and monoclonal antibodies. It has enormous potential to revolutionize the medical and clinical medicines. rDNA technology has triggered the biopharmaceutical industries towards the development of various rDNA product, in turn favoring the growth of recombinant DNA technology market.

Global Recombinant DNA Technology Market Taxonomy

By Types-

  • Expression system
    • Mammalian
    • Bacteria
    • Yeast
    • Insect
  • Cloning vector
    • Plasmid
    • Phage
    • Cosmid
    • BAC
    • YAC
    • HAC

By Product –

  • Medical
    • Therapeutic Agent
    • Human Protein
    • Vaccines
  • Non-Medical
    • Biotech Crops

By Application –

  • Health And Disease
  • Food And Agriculture
  • Environment

By End User –

  • Research institutes
  • Biotechnology companies
  • Pharmaceuticals

Global recombinant DNA technology market – trends and opportunity

At Jef Boeke’s lab, 2017, scientists are rewriting the yeast genome, which aims to create custom-made chunks of DNA codes, which can be inserted into the cells to alter their functions and improve drug development. Researchers intend to construct whole new organisms with functional genes, which will help to develop vaccines, proteins, drugs, and biofuels.

According to Applied Science Report, 2013, integrating biotechnology and genomics in the drug development process gives the opportunity to companies to save up to US$ 300 million per drug, which is about one-third of the cost of the drug. This prospect is bringing drug two year earlier in the market, indicating the significance of recombinant drugs and the need for manufacturing.

Increasing investments in research and development pool to favor the growth of recombinant DNA technology

Increasing government funding in the U.S. by the Department of Health And Human Services (HHS) to National Institute of Health’s research and development for various disciplinary field gene therapy applications is the major driving factor for the growth of recombinant DNA technology market. Effect of various factors, such as food, health problems, and environmental issues on growing population is another driving factor for the growth of recombinant DNA technology market. Diseases such as cancers, genetic disorder, plant and animal disorders, and development of anti-fungal or anti-viral abilities of plants have high demand in therapeutic approaches, which will favor the growth of recombinant DNA technology market.

Lack of government funding for research and development in emerging economies is the major restraint for the growth of recombinant DNA technology market.

The major key players operating the recombinant DNA technology market include Horizon Discovery Group PLC, F. Hoffmann-La Roche Ltd (Genentech, Inc), Profacgen, Cibus; Monsanto Company, Amgen Inc., New England Biolabs, Novartis AG, GenScript, GlaxoSmithKline plc, Pfizer Inc., Novo Nordisk, and Eli Lilly and Company.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.
Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.